One of the largest pharmaceutical companies in the world, McKesson, delivers up to one-third of the drugs and medications in the United States. In 2019, the company grossed $214,319,000,000. With the current crisis and the need for new medicines including a vaccine, it is poised to continue growing. However, much of McKesson’s growth has been extremely controversial. Therefore, any gains that it makes during the current crisis may be a breeding ground for litigation.
Much of McKesson’s growth over the past few years has been due to a higher number of people using prescription medications and higher prices of those prescriptions – both of which are incredibly controversial. McKesson has been under litigation for its role in the current opioid crisis by making opioids too accessible to people addicted to them. The company remains under a federal criminal investigation. Any profiteering over the need for new medications, including the vaccine, may backfire.